Skip to main content
. 2002 Dec 26;2:37. doi: 10.1186/1471-2407-2-37

Table 15.

Estimated global and regional number of new cases and age-standardised incidence rate of cancer by site, females, 2000

WHO sub region

World AFRO AMRO EMRO EURO SEARO WPRO






Site D E A B D B D A B1 B2 C B D A B1 B2 B3
Number of new cases (000s)
Mouth and oropharynx cancers 153.6 8.2 11.4 5.9 4.6 0.8 2.2 1.1 9.9 2.5 0.5 4.6 9.4 63.6 3.0 21.2 4.2 0.4
Oesophagus cancer 166.2 4.2 7.2 3.3 4.0 0.3 1.6 0.5 8.4 1.0 1.3 3.8 2.5 34.9 2.1 89.0 2.0 0.0
Stomach cancer 383.9 10.3 8.4 7.1 19.7 8.4 4.5 2.0 33.9 10.2 2.6 36.3 6.7 18.1 23.7 186.7 5.1 0.1
Colon and rectum cancers 517.3 8.5 8.2 73.8 26.2 3.3 4.0 2.8 131.0 19.0 1.8 54.1 22.8 21.1 41.7 95.5 3.3 0.1
Liver cancer 204.4 11.9 11.1 4.7 9.7 3.4 1.3 1.2 14.0 4.0 0.5 5.9 11.7 12.0 11.1 99.6 2.2 0.2
Pancreas cancer 106.9 1.6 2.6 14.3 9.1 1.3 0.8 0.7 28.1 4.8 0.7 10.2 3.6 5.3 9.8 13.6 0.5 0.0
Trachea, bronchus, lung cancers 365.7 3.1 5.0 74.6 16.4 1.0 3.0 2.6 55.3 10.8 1.1 17.7 8.3 25.9 18.9 117.7 4.0 0.2
Melanoma of the skin 88.5 3.3 4.3 26.5 5.7 0.9 0.4 0.3 26.5 3.5 0.3 5.9 1.9 1.7 5.0 2.2 0.1 0.1
Breast cancer 1031.9 28.3 39.8 226.5 59.3 7.2 10.2 13.6 221.8 32.6 4.5 68.5 53.9 109.0 43.7 102.1 10.2 0.5
Cervix uteri cancer 487.5 43.3 67.9 16.1 40.6 9.2 6.7 5.6 18.8 12.6 1.9 22.5 32.8 146.7 6.6 45.0 10.2 0.8
Corpus uteri cancer 326.3 4.6 6.0 46.0 48.8 8.6 1.6 1.3 68.3 17.9 3.8 43.6 19.9 11.7 17.3 17.4 0.8 0.1
Ovary cancer 221.3 7.1 12.2 22.4 13.2 2.1 2.1 2.0 39.4 10.0 1.2 21.6 18.1 31.9 8.4 26.6 2.9 0.2
Prostate cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Bladder cancer 105.7 3.6 3.4 14.9 3.5 0.4 0.8 3.7 21.4 2.7 0.3 4.4 2.4 28.9 4.6 9.7 1.0 0.0
Lymphomas, multiple myeloma 242.6 10.2 8.0 32.2 12.4 2.3 5.0 4.0 40.9 6.9 1.0 7.3 9.6 74.9 9.7 15.2 2.7 0.1
Leukaemia 169.5 5.9 7.0 14.7 12.4 2.9 2.6 3.8 23.0 4.9 0.9 9.0 10.8 24.9 5.2 39.4 1.9 0.1
Other malignant neoplasms 553.9 44.2 22.7 63.6 56.7 11.7 8.9 8.9 107.3 25.3 4.4 46.5 27.3 31.7 32.7 56.1 5.3 0.3

Age-standardised incidence rate per 100,000
Mouth and oropharynx cancers 5.1 9.2 12.6 2.6 2.4 3.4 4.6 2.2 2.7 2.5 2.5 2.2 5.7 13.5 2.2 3.1 7.7 18.6
Oesophagus cancer 5.6 5.2 9.2 1.3 2.2 1.5 4.0 1.1 1.8 1.0 6.5 1.5 1.7 8.0 1.3 13.4 3.9 1.8
Stomach cancer 12.8 12.7 10.5 2.9 10.7 37.4 10.9 4.3 7.3 9.4 12.4 15.6 4.4 4.3 14.9 28.2 10.1 3.1
Colon and rectum cancers 17.3 9.9 10.2 29.8 14.1 14.4 9.4 5.9 29.2 17.2 8.6 23.0 14.7 4.7 26.7 14.2 6.3 4.2
Liver cancer 6.8 13.0 12.0 1.9 5.2 14.6 3.1 2.5 3.1 3.6 2.3 2.5 7.5 2.3 6.6 14.8 4.2 7.6
Pancreas cancer 3.6 1.8 3.5 5.6 5.0 5.8 1.9 1.6 6.0 4.3 3.6 4.3 2.4 1.3 5.8 2.1 0.9 0.4
Trachea, bronchus, lung cancers 11.9 3.5 5.8 30.5 8.8 4.4 6.7 5.6 13.4 9.9 5.5 7.6 5.4 5.3 11.6 16.0 7.4 8.4
Melanoma of the skin 2.9 3.9 5.3 12.6 2.9 4.0 0.8 0.6 7.9 3.4 1.4 3.2 1.2 0.3 4.2 0.3 0.2 2.8
Breast cancer 34.2 29.9 41.6 103.5 29.7 27.6 22.5 26.2 64.1 32.0 21.2 35.4 30.7 20.9 38.6 14.1 18.5 21.9
Cervix uteri cancer 16.6 43.3 69.8 8.2 19.8 34.9 15.0 10.7 6.2 12.8 9.0 12.7 18.4 30.2 6.0 6.6 18.0 33.1
Corpus uteri cancer 10.8 5.2 6.8 20.3 24.5 32.8 3.7 2.8 18.4 17.1 18.1 21.2 11.5 2.1 13.3 2.4 1.5 5.2
Ovary cancer 7.3 6.8 12.1 9.8 6.6 7.9 4.3 3.7 10.8 9.9 5.6 11.2 10.2 6.2 6.8 3.6 5.0 6.3
Prostate cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Bladder cancer 3.6 4.1 3.9 6.0 1.9 1.8 2.2 7.9 4.6 2.4 1.5 1.9 1.6 5.7 2.7 1.5 1.8 0.6
Lymphomas, multiple myeloma 8.3 9.1 7.7 13.8 6.3 9.2 9.9 7.2 10.6 7.0 4.4 4.0 5.8 15.7 6.7 2.2 4.4 4.8
Leukaemia 5.5 5.6 6.1 6.6 6.0 9.1 4.3 5.9 6.0 5.2 3.8 5.2 6.0 3.9 4.4 5.8 3.0 2.9
Other malignant neoplasms 18.8 45.9 24.0 30.2 28.6 44.0 20.0 17.2 29.6 24.9 19.6 25.8 16.1 6.1 23.3 10.7 9.4 129
HHS Vulnerability Disclosure